Recordati Industria Chimica e Farmaceutica S.p.A. (BIT:REC)
Italy
· Delayed Price · Currency is EUR 49.82
+0.06 (0.12%)
Apr 28, 2026, 5:37 PM CET
BIT:REC Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Revenue | 2,618 | 2,342 | 2,082 | 1,853 | 1,580 | Upgrade
|
| Revenue Growth (YoY) | 11.82% | 12.45% | 12.36% | 17.29% | 9.06% | Upgrade
|
| Cost of Revenue | 763.94 | 703.78 | 600.76 | 516.93 | 427.73 | Upgrade
|
| Gross Profit | 1,854 | 1,638 | 1,482 | 1,336 | 1,152 | Upgrade
|
| Selling, General & Admin | 727.36 | 654.76 | 601.51 | 572.3 | 481.01 | Upgrade
|
| Research & Development | 340.95 | 286.03 | 255.75 | 220.1 | 166.14 | Upgrade
|
| Other Operating Expenses | 1.89 | -1.37 | -2.25 | -0.5 | 0.65 | Upgrade
|
| Operating Expenses | 1,070 | 939.42 | 855.01 | 791.91 | 647.8 | Upgrade
|
| Operating Income | 784.25 | 698.36 | 626.56 | 544.47 | 504.55 | Upgrade
|
| Interest Expense | -98.92 | -81.16 | -74.46 | -34.45 | -20.9 | Upgrade
|
| Interest & Investment Income | 0.07 | 5.96 | 4.18 | - | - | Upgrade
|
| Currency Exchange Gain (Loss) | 14.98 | -9.34 | 2.16 | -5.8 | -5.82 | Upgrade
|
| EBT Excluding Unusual Items | 700.38 | 613.82 | 558.44 | 504.22 | 477.83 | Upgrade
|
| Merger & Restructuring Charges | -88.82 | -45.43 | -67.95 | -93.47 | -11.73 | Upgrade
|
| Asset Writedown | -9.73 | -14.33 | -0.37 | -10.93 | -0.05 | Upgrade
|
| Other Unusual Items | -20.55 | -6.87 | 0.91 | 1.62 | -2.69 | Upgrade
|
| Pretax Income | 581.27 | 547.18 | 491.04 | 401.44 | 463.35 | Upgrade
|
| Income Tax Expense | 137.65 | 130.68 | 101.82 | 89.1 | 77.38 | Upgrade
|
| Earnings From Continuing Operations | 443.62 | 416.51 | 389.21 | 312.34 | 385.97 | Upgrade
|
| Net Income | 443.62 | 416.51 | 389.21 | 312.34 | 385.97 | Upgrade
|
| Net Income to Common | 443.62 | 416.51 | 389.21 | 312.34 | 385.97 | Upgrade
|
| Net Income Growth | 6.51% | 7.01% | 24.61% | -19.08% | 8.73% | Upgrade
|
| Shares Outstanding (Basic) | 205 | 206 | 206 | 206 | 206 | Upgrade
|
| Shares Outstanding (Diluted) | 209 | 209 | 209 | 209 | 209 | Upgrade
|
| Shares Change (YoY) | - | -0.01% | 0.04% | -0.01% | 0.01% | Upgrade
|
| EPS (Basic) | 2.16 | 2.02 | 1.89 | 1.52 | 1.87 | Upgrade
|
| EPS (Diluted) | 2.12 | 1.99 | 1.86 | 1.49 | 1.85 | Upgrade
|
| EPS Growth | 6.48% | 7.04% | 24.57% | -19.07% | 8.72% | Upgrade
|
| Free Cash Flow | 557.45 | 533.27 | 455.63 | 437.8 | 469.8 | Upgrade
|
| Free Cash Flow Per Share | 2.67 | 2.55 | 2.18 | 2.09 | 2.25 | Upgrade
|
| Dividend Per Share | 1.340 | 1.270 | 1.200 | 1.150 | 1.100 | Upgrade
|
| Dividend Growth | 5.51% | 5.83% | 4.35% | 4.54% | 4.76% | Upgrade
|
| Gross Margin | 70.82% | 69.94% | 71.15% | 72.11% | 72.93% | Upgrade
|
| Operating Margin | 29.95% | 29.83% | 30.09% | 29.38% | 31.93% | Upgrade
|
| Profit Margin | 16.94% | 17.79% | 18.69% | 16.85% | 24.43% | Upgrade
|
| Free Cash Flow Margin | 21.29% | 22.77% | 21.88% | 23.62% | 29.73% | Upgrade
|
| EBITDA | 977.05 | 852.08 | 757.12 | 659.21 | 592.2 | Upgrade
|
| EBITDA Margin | 37.31% | 36.39% | 36.36% | 35.57% | 37.48% | Upgrade
|
| D&A For EBITDA | 192.8 | 153.72 | 130.56 | 114.73 | 87.65 | Upgrade
|
| EBIT | 784.25 | 698.36 | 626.56 | 544.47 | 504.55 | Upgrade
|
| EBIT Margin | 29.95% | 29.83% | 30.09% | 29.38% | 31.93% | Upgrade
|
| Effective Tax Rate | 23.68% | 23.88% | 20.74% | 22.20% | 16.70% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.